|
|
Ph-positive leukemias in the era of modern cytogenetics, molecular biology, tyrosine kinase inhibitors and hematopoietic stem cell transplantationKeywords: Ph-positive leukemias , diagnosis , treatment , tyrosine-kinase inhibitors , ABL-BCR mutations , hematopoietic stem cell transplantation , cytogenetic and molecular monitoring , prognosis Abstract: The review is devoted to the complex problems of modern cytogenetic and molecular diagnostics of Ph-positive leukemias, their treatment in era tyrosine kinase inhibitors and hematopoietic stem cell transplantation at the condition of cytogenetic and molecular monitoring.
|
